Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study evaluates humoral and cellular immune memory induced by different COVID-19 vaccines

Study evaluates humoral and cellular immune memory induced by different COVID-19 vaccines

Study explores favorable signatures for specific RNA motif recognition by SARS-CoV-2 nucleocapsid

Study explores favorable signatures for specific RNA motif recognition by SARS-CoV-2 nucleocapsid

New SARS-CoV-2 Omicron-Delta recombinant virus identified in the US

New SARS-CoV-2 Omicron-Delta recombinant virus identified in the US

Study elucidates importation risks and disproportionate spread of SARS-CoV-2 variants of concern in the Netherlands

Study elucidates importation risks and disproportionate spread of SARS-CoV-2 variants of concern in the Netherlands

Study finds that Omicron variant preferentially uses the endosome pathway through mutation in the spike protein

Study finds that Omicron variant preferentially uses the endosome pathway through mutation in the spike protein

Study evaluates mutation-induced SARS-CoV-2 spike protein fold stability

Study evaluates mutation-induced SARS-CoV-2 spike protein fold stability

Study finds fractionation of sulfated galactan from red alga can isolate its anti-SARS-CoV-2 properties

Study finds fractionation of sulfated galactan from red alga can isolate its anti-SARS-CoV-2 properties

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Study identified multiple siRNAs spanning the SARS-CoV-2 genome with potent antiviral activity

Study identified multiple siRNAs spanning the SARS-CoV-2 genome with potent antiviral activity

Uptake of SARS-CoV-2 spike protein in human cerebrovascular cells

Uptake of SARS-CoV-2 spike protein in human cerebrovascular cells

Study evaluates the prevalence of autoantibodies targeting type I interferons in critically-ill COVID-19 patients

Study evaluates the prevalence of autoantibodies targeting type I interferons in critically-ill COVID-19 patients

Breathlessness and fatigue most common in self reported long-COVID

Breathlessness and fatigue most common in self reported long-COVID

SARS-CoV-2 is evolving adaptively in multiple regions of the genome

SARS-CoV-2 is evolving adaptively in multiple regions of the genome

T-cell and neutralizing antibody response after a third COVID-19 vaccine dose in hemodialysis patients

T-cell and neutralizing antibody response after a third COVID-19 vaccine dose in hemodialysis patients

Researchers investigate Galectin-9 as a new treatment target for COVID-19

Researchers investigate Galectin-9 as a new treatment target for COVID-19

Study confirms no preexisting B-cell immunity against SARS-CoV-2 in pre-pandemic samples

Study confirms no preexisting B-cell immunity against SARS-CoV-2 in pre-pandemic samples

Recombinant SARS-CoV-2 Delta-Omicron variant identified in the United States

Recombinant SARS-CoV-2 Delta-Omicron variant identified in the United States

SARS-CoV-2 mRNA vaccines may prevent COVID-19-associated mechanical ventilation and death

SARS-CoV-2 mRNA vaccines may prevent COVID-19-associated mechanical ventilation and death

Monoclonal antibodies found to prevent lung inflammation in SARS-CoV-2-Omicron-infected mice

Monoclonal antibodies found to prevent lung inflammation in SARS-CoV-2-Omicron-infected mice

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.